Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Gene Therapy
|
August 24, 1999
Cellular contaminants of adeno-associated virus vector stocks can enhance transduction
L Tenenbaum, M Hamdane, M Pouzet, et al.
American Journal of Human Genetics
|
November 13, 2001
Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene
D Kaufmann, R Müller, B Bartelt, et al.
Journal of Neuroscience Research
|
April 1, 1994
Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies
C O Hanemann, G Stoll, D D'Urso, et al.
BMJ Open
|
June 16, 2026
Repurposing anti-retroviral drugs to treat NF2-related tumours: a protocol for a phase 0 trial (RETREAT)
Sarah Campbell, Katherine Beaney, Joanne Hosking, et al.
Nature Genetics
|
June 1, 1992
Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A
N Matsunami, B Smith, L Ballard, et al.
Oncogene
|
November 10, 2015
The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors
L Zhou, J Lyons-Rimmer, S Ammoun, et al.
Annals of Neurology
|
October 23, 1997
Congenital axonal neuropathy caused by deletions in the spinal muscular atrophy region
R Korinthenberg, M Sauer, U P Ketelsen, et al.
Neurology
|
August 25, 2004
Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS
C Münch, R Sedlmeier, T Meyer, et al.
Nature Genetics
|
June 1, 1992
The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication
V Timmerman, E Nelis, W Van Hul, et al.
Oncogene
|
July 11, 2017
Cellular prion protein (PrP<sup>C</sup>) in the development of Merlin-deficient tumours
L Provenzano, Y Ryan, D A Hilton, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Gene Therapy
|
August 24, 1999
Cellular contaminants of adeno-associated virus vector stocks can enhance transduction
L Tenenbaum, M Hamdane, M Pouzet, et al.
American Journal of Human Genetics
|
November 13, 2001
Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene
D Kaufmann, R Müller, B Bartelt, et al.
Journal of Neuroscience Research
|
April 1, 1994
Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies
C O Hanemann, G Stoll, D D'Urso, et al.
BMJ Open
|
June 16, 2026
Repurposing anti-retroviral drugs to treat NF2-related tumours: a protocol for a phase 0 trial (RETREAT)
Sarah Campbell, Katherine Beaney, Joanne Hosking, et al.
Nature Genetics
|
June 1, 1992
Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A
N Matsunami, B Smith, L Ballard, et al.
Oncogene
|
November 10, 2015
The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors
L Zhou, J Lyons-Rimmer, S Ammoun, et al.
Annals of Neurology
|
October 23, 1997
Congenital axonal neuropathy caused by deletions in the spinal muscular atrophy region
R Korinthenberg, M Sauer, U P Ketelsen, et al.
Neurology
|
August 25, 2004
Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS
C Münch, R Sedlmeier, T Meyer, et al.
Nature Genetics
|
June 1, 1992
The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication
V Timmerman, E Nelis, W Van Hul, et al.
Oncogene
|
July 11, 2017
Cellular prion protein (PrP<sup>C</sup>) in the development of Merlin-deficient tumours
L Provenzano, Y Ryan, D A Hilton, et al.
Page
of 6